Haleon plc (LON:HLN)

Market Cap	32.17B
Revenue (ttm)	11.02B
Net Income (ttm)	1.52B
Shares Out	8.91B
EPS (ttm)	0.17
PE Ratio	21.64
Forward PE	18.71
Dividend	0.07 (1.90%)
Ex-Dividend Date	Aug 14, 2025

Volume	12,109,183
Average Volume	20,144,358
Open	359.40
Previous Close	358.50
Day's Range	356.00 - 361.80
52-Week Range	274.40 - 419.50
Beta	0.23
RSI	65.79
Earnings Date	Feb 25, 2026

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprisi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1715
• Employees: 24,561
• Stock Exchange: London Stock Exchange
• Ticker Symbol: HLN

Financial Performance

In 2024, Haleon's revenue was 11.23 billion, a decrease of -0.61% compared to the previous year's 11.30 billion. Earnings were 1.44 billion, an increase of 37.46%.